ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 2170

$1.37M Total Retail Price of All Prescriptions

Rank: 25 out of 2170

544 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 544 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 544 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 21,153 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 853 780 1 6
SIMVASTATIN 774 702 2 1
OMEPRAZOLE 668 579 3 2
LISINOPRIL 662 640 4 3
WARFARIN SODIUM 606 576 5 15
AMLODIPINE BESYLATE 549 512 6 4
LEVOTHYROXINE SODIUM 525 494 7 5
GABAPENTIN 523 464 8 14
POTASSIUM CHLORIDE 515 492 9 16
DONEPEZIL HCL 420 408 10 32
OXYCODONE-ACETAMINOPHEN 391 320 S2 11 60
METOPROLOL TARTRATE 376 351 12 10
HYDROCODONE-ACETAMINOPHEN 339 263 S3 13 7
ATENOLOL 327 305 14 23
MIRTAZAPINE 313 295 15 46
NAMENDA 313 313 15 48
SERTRALINE HCL 306 287 17 25
NOVOLIN R 273 262 18 149
HYDRALAZINE HCL 243 238 19 84
HYDROCHLOROTHIAZIDE 224 193 20 9
ATORVASTATIN CALCIUM 222 217 21 12
PANTOPRAZOLE SODIUM 211 199 22 39
EXELON 194 194 23 119
NEXIUM 192 178 24 22
LANTUS 189 188 25 51
ZOLPIDEM TARTRATE 188 147 26 17
METFORMIN HCL 186 168 27 8
ALENDRONATE SODIUM 182 170 28 36
TRAMADOL HCL 180 179 29 18
PRAVASTATIN SODIUM 177 164 30 11
CIPROFLOXACIN HCL 171 156 31 69
CARVEDILOL 166 163 32 26
CLOPIDOGREL 165 162 33 37
RISPERIDONE 156 137 34 73
LOVASTATIN 153 135 35 34
CITALOPRAM HBR 151 140 36 19
CARBIDOPA-LEVODOPA 150 150 37 110
METOPROLOL SUCCINATE 146 124 38 13
PREDNISONE 145 124 39 41
ADVAIR DISKUS 145 143 39 45
LOSARTAN POTASSIUM 142 123 41 21
FENTANYL 139 102 S2 42 87
MELOXICAM 137 128 43 28
OXYBUTYNIN CHLORIDE 137 120 43 164
TAMSULOSIN HCL 126 113 45 33
KLOR-CON M20 125 122 46 68
TRAZODONE HCL 124 122 47 38
SPIRIVA 122 112 48 49
OLANZAPINE 121 121 49 139
GLIPIZIDE 120 120 50 62
ALLOPURINOL 119 119 51 29
CYMBALTA 118 107 52 44
PAROXETINE HCL 116 89 53 65
ISOSORBIDE MONONITRATE ER 116 116 53 50
DILTIAZEM HCL 115 113 55 224
DILTIAZEM 24HR CD 110 108 56 82
ESCITALOPRAM OXALATE 109 101 57 75
METFORMIN HCL ER 103 67 58 35
IBUPROFEN 101 72 59 105
QUETIAPINE FUMARATE 99 99 60 88
LEVETIRACETAM 99 75 60 109
CLONIDINE HCL 98 92 62 54
RANITIDINE HCL 95 73 63 40
ALBUTEROL SULFATE 94 91 64 167
PLAVIX 92 87 65 58
LIDODERM 88 88 66 162
CEPHALEXIN 88 83 66 120
NIFEDIPINE ER 87 75 68 129
LANTUS SOLOSTAR 86 81 69 79
DOXAZOSIN MESYLATE 80 80 70 93
TERAZOSIN HCL 80 56 70 156
GLIPIZIDE ER 79 58 72 86
SANTYL 78 71 73 221
OXYCODONE HCL-ACETAMINOPHEN 78 65 S2 73 74
KLOR-CON M10 77 71 75 132
NIFEDIAC CC 77 62 75 306
FAMOTIDINE 75 75 77 96
DIGOXIN 75 68 77 72
AZITHROMYCIN 74 72 79 47
FLUOXETINE HCL 74 71 79 59
NOVOLOG 74 74 79 98
ISOSORBIDE DINITRATE 74 74 79 229
DIOVAN 73 67 83 53
LACTULOSE 72 47 84 125
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 68 84 20
POLYETHYLENE GLYCOL 3350 72 53 84 63
NITROFURANTOIN MONO-MACRO 71 71 87 196
METOCLOPRAMIDE HCL 70 59 88 127
NITROGLYCERIN PATCH 68 68 89 232
ZETIA 68 61 89 78
BACLOFEN 63 38 91 137
PROMETHAZINE HCL 61 54 R 92 70
CRESTOR 60 60 93 24
DIVALPROEX SODIUM 60 48 93 91
PROCRIT 59 59 95 298
SINGULAIR 59 45 95 85
TRILIPIX 58 35 97 187
OXYBUTYNIN CHLORIDE ER 58 47 97 148
ACETAMINOPHEN-CODEINE 57 31 S3 99 206
TRICOR 57 57 99 130
AMOX TR-POTASSIUM CLAVULANATE 56 39 101 126
PRAMIPEXOLE DIHYDROCHLORIDE 56 56 101 200
ACTOS 55 46 103 108
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 104 42
RIVASTIGMINE 54 54 104 295
COMBIVENT 54 46 104 112
BENZTROPINE MESYLATE 54 54 R 104 172
TRIAMTERENE-HYDROCHLOROTHIAZID 54 32 104 202
IPRATROPIUM-ALBUTEROL 53 51 109 131
METHOCARBAMOL 53 42 R 109 205
GLIMEPIRIDE 53 53 109 31
GLIPIZIDE XL 51 51 112 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.